EP3880690A4 - Peptides and pharmaceutical compositions for treating eye diseases - Google Patents
Peptides and pharmaceutical compositions for treating eye diseases Download PDFInfo
- Publication number
- EP3880690A4 EP3880690A4 EP19883897.1A EP19883897A EP3880690A4 EP 3880690 A4 EP3880690 A4 EP 3880690A4 EP 19883897 A EP19883897 A EP 19883897A EP 3880690 A4 EP3880690 A4 EP 3880690A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- peptides
- pharmaceutical compositions
- eye diseases
- treating eye
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Immunology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862767180P | 2018-11-14 | 2018-11-14 | |
| PCT/IB2019/001220 WO2020099925A2 (en) | 2018-11-14 | 2019-11-14 | Peptides and pharmaceutical compositions for treating eye diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP3880690A2 EP3880690A2 (en) | 2021-09-22 |
| EP3880690A4 true EP3880690A4 (en) | 2023-09-13 |
Family
ID=70732068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP19883897.1A Pending EP3880690A4 (en) | 2018-11-14 | 2019-11-14 | Peptides and pharmaceutical compositions for treating eye diseases |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP3880690A4 (en) |
| JP (1) | JP7522732B2 (en) |
| KR (1) | KR20210087539A (en) |
| CN (1) | CN113474356B (en) |
| AU (1) | AU2019378162B2 (en) |
| BR (1) | BR112021009341A2 (en) |
| CA (1) | CA3119921A1 (en) |
| MX (1) | MX2021005077A (en) |
| SG (1) | SG11202104178TA (en) |
| TW (1) | TWI865470B (en) |
| WO (1) | WO2020099925A2 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110945012A (en) * | 2017-05-17 | 2020-03-31 | 株式会社柳柳制药 | Novel peptide and pharmaceutical composition for treating ocular diseases comprising the same as active pharmaceutical ingredient |
| US11613558B2 (en) | 2018-11-14 | 2023-03-28 | Yuyu Pharma, Inc. | Peptides and pharmaceutical compositions for treating eye diseases |
| PL3974441T3 (en) | 2019-05-21 | 2025-04-07 | Eyebio Korea | Peptide compound or pharmaceutically acceptable salt thereof |
| KR20220149745A (en) * | 2020-03-05 | 2022-11-08 | 주식회사 유유제약 | Treatment and pharmaceutical composition of inflammatory diseases using peptides |
| KR102662922B1 (en) * | 2022-05-31 | 2024-05-03 | 주식회사 세네릭스 | Novel D-amino acid derivatives and compositions comprising the same |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6037135A (en) * | 1992-08-07 | 2000-03-14 | Epimmune Inc. | Methods for making HLA binding peptides and their uses |
| WO2017175963A1 (en) * | 2016-04-08 | 2017-10-12 | 주식회사 아이바이오코리아 | Chondrocyte extracellular matrix-derived peptide |
| EP3329929A1 (en) * | 2015-07-30 | 2018-06-06 | Inje University Industry-Academic Cooperation Foundation | Pharmaceutical composition for preventing or treating dry eyes |
| EP3643723A1 (en) * | 2017-05-17 | 2020-04-29 | Yuyu Pharma, Inc. | Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101795653B1 (en) * | 2016-05-19 | 2017-11-09 | 인제대학교 산학협력단 | Composition for inhibiting angiogenesis comprising chimeric protein of collagen type II peptide-Aflibercept |
| KR20180074928A (en) * | 2016-12-26 | 2018-07-04 | 주식회사 아이바이오코리아 | Animal medicine composition for preventing or treating dry eye |
-
2019
- 2019-11-13 TW TW108141290A patent/TWI865470B/en active
- 2019-11-14 BR BR112021009341-9A patent/BR112021009341A2/en unknown
- 2019-11-14 CA CA3119921A patent/CA3119921A1/en active Pending
- 2019-11-14 CN CN201980078779.XA patent/CN113474356B/en active Active
- 2019-11-14 SG SG11202104178TA patent/SG11202104178TA/en unknown
- 2019-11-14 JP JP2021526304A patent/JP7522732B2/en active Active
- 2019-11-14 WO PCT/IB2019/001220 patent/WO2020099925A2/en not_active Ceased
- 2019-11-14 MX MX2021005077A patent/MX2021005077A/en unknown
- 2019-11-14 EP EP19883897.1A patent/EP3880690A4/en active Pending
- 2019-11-14 KR KR1020217018226A patent/KR20210087539A/en active Pending
- 2019-11-14 AU AU2019378162A patent/AU2019378162B2/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6037135A (en) * | 1992-08-07 | 2000-03-14 | Epimmune Inc. | Methods for making HLA binding peptides and their uses |
| EP3329929A1 (en) * | 2015-07-30 | 2018-06-06 | Inje University Industry-Academic Cooperation Foundation | Pharmaceutical composition for preventing or treating dry eyes |
| WO2017175963A1 (en) * | 2016-04-08 | 2017-10-12 | 주식회사 아이바이오코리아 | Chondrocyte extracellular matrix-derived peptide |
| EP3441081A1 (en) * | 2016-04-08 | 2019-02-13 | Eyebio Korea | Chondrocyte extracellular matrix-derived peptide |
| EP3643723A1 (en) * | 2017-05-17 | 2020-04-29 | Yuyu Pharma, Inc. | Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient |
Also Published As
| Publication number | Publication date |
|---|---|
| BR112021009341A2 (en) | 2021-08-10 |
| AU2019378162A1 (en) | 2021-05-20 |
| WO2020099925A2 (en) | 2020-05-22 |
| JP2022507404A (en) | 2022-01-18 |
| MX2021005077A (en) | 2021-08-11 |
| WO2020099925A3 (en) | 2020-06-25 |
| CN113474356A (en) | 2021-10-01 |
| KR20210087539A (en) | 2021-07-12 |
| EP3880690A2 (en) | 2021-09-22 |
| CN113474356B (en) | 2024-12-17 |
| SG11202104178TA (en) | 2021-05-28 |
| TW202031675A (en) | 2020-09-01 |
| AU2019378162B2 (en) | 2025-01-30 |
| TWI865470B (en) | 2024-12-11 |
| CA3119921A1 (en) | 2020-05-22 |
| JP7522732B2 (en) | 2024-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276464A (en) | Methods and compositions for therapeutic protein delivery | |
| EP3880690A4 (en) | Peptides and pharmaceutical compositions for treating eye diseases | |
| EP3238736A4 (en) | Peptide for treating ocular diseases and composition for treating ocular diseases comprising same | |
| IL284344A (en) | Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease | |
| EP3934646A4 (en) | Pharmaceutical compositions for treating ocular diseases or disorders | |
| IL276244A (en) | Ophthalmic pharmaceutical composition, preparation method therefor and application thereof | |
| SG11201912110YA (en) | Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient | |
| EP3192875A4 (en) | Sustained-release pharmaceutical composition for treating and preventing ophthalmic diseases | |
| EP3723750A4 (en) | Drugs and compositions for ocular delivery | |
| EP3818081A4 (en) | Compositions and methods for treating inflammasome related diseases or conditions | |
| EP3691654A4 (en) | Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease | |
| EP3634438A4 (en) | Compositions for treating retinal diseases and methods for making and using them | |
| IL280952A (en) | Methods and compositions for drugs to treat ophthalmic diseases | |
| EP3831365A4 (en) | Pharmaceutical composition for preventing or treating atopic diseases | |
| EP3768095A4 (en) | Compositions and methods for treating diarrheal diseases | |
| EP3265103A4 (en) | Compositions and methods for treating ocular diseases | |
| EP3993833A4 (en) | Compositions and methods for treating eye diseases | |
| EP3672583A4 (en) | Compositions and methods for treating neurodegenerative diseases | |
| HK40061089B (en) | Peptides and pharmaceutical compositions for treating eye diseases | |
| EP3856210A4 (en) | Extracellular matrix protein compositions and methods for treating wounds | |
| EP3823635A4 (en) | Corneal epithelial cells and their products for treating corneal diseases | |
| HK40042312A (en) | Methods and compositions for therapeutic protein delivery | |
| HK40074800A (en) | Peptides and methods for treating diseases | |
| HK40056006A (en) | Methods and compositions for drugs to treat ophthalmic diseases | |
| HK40053279A (en) | Compositions and methods for treating nrp2-associated diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20210614 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230330 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 38/00 20060101ALI20230510BHEP Ipc: A61P 27/02 20060101ALI20230510BHEP Ipc: A61K 9/00 20060101ALI20230510BHEP Ipc: C07K 7/06 20060101AFI20230510BHEP |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20230817 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 38/00 20060101ALI20230810BHEP Ipc: A61P 27/02 20060101ALI20230810BHEP Ipc: A61K 9/00 20060101ALI20230810BHEP Ipc: C07K 7/06 20060101AFI20230810BHEP |